You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長春高新(000661.SZ)及百克生物與思安信終止新冠疫苗(PIV-5載體)許可合作

格隆匯9月27日丨長春高新(000661.SZ)公佈,受近期國內外病毒變異及疫情流行情況變化的影響,為保證新型冠狀病毒疫苗(PIV-5載體)研發的順利進行,長春高新、百克生物(688276.SH)擬對思安信新型冠狀病毒疫苗(PIV-5載體)應對變異毒株的效力進行技術可行性的驗證,驗證後簽署正式協議;思安信不同意在沒有簽署正式協議前提下移交生物材料用以開展驗證性實驗;同時,鑑於該疫苗在美國已經開展I期臨牀試驗,思安信要求提升項目估值。交易各方認為有必要對包括驗證方案在內的研發節奏、交易對價等內容進行進一步磋商,經充分探討與溝通,各方最終無法就上述內容達成一致意見,各方一致同意終止該《許可合作協議》正式簽署及後續合作事宜。

長春高新、百克生物與思安信關於新型冠狀病毒疫苗(PIV-5載體)許可合作協議中約定提前終止的條款,其中包括“經各方書面同意”可提前終止協議。截至該公吿發布日止,協議尚未正式簽署,不涉及賠償事宜。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account